Image

Global Temporal Arteritis Market – Industry Trends and Forecast to 2029

Pharmaceutical

Image

Global Temporal Arteritis Market – Industry Trends and Forecast to 2029

  • Pharmaceutical
  • Upcoming Report
  • Nov 2022
  • Global
  • 350 Pages
  • No of Tables: 220
  • No of Figures: 60

Global Temporal Arteritis Market, Treatment (Corticosteroids, Immunosuppressive Agents, Anticoagulants, Others), Route of Administration (Oral, Parenteral), End-Users (Hospitals, Homecare, Specialty Clinics, Others), Distribution Channel (Hospital Pharmacy, Online Pharmacy, Retail Pharmacy) – Industry Trends and Forecast to 2029.

Temporal arteritis Market

Temporal arteritis Market Analysis and Size

The global temporal arteritis market is expected to witness significant growth during the forecast period. Etiology of temporal arteritis was not known until now but it may be linked with the body's autoimmune system. In addition to this, higher dose of antibiotics and several severe infections have been associated with temporal arteritis. There is no prevention or treatment available yet for temporal arteritis. Though, after diagnosis of temporal arteritis it can be treated by diminishing complications.

Data Bridge Market Research analyses a growth rate in the global temporal arteritis market in the forecast period 2022-2029. In addition to the market insights such as market value, growth rate, market segments, geographical coverage, market players, and market scenario, the market report curated by the Data Bridge Market Research team also includes in-depth expert analysis, patient epidemiology, pipeline analysis, pricing analysis, and regulatory framework.

Temporal arteritis Market Scope and Segmentation

Report Metric

Details

Forecast Period

2022 to 2029

Base Year

2021

Historic Years

2020 (Customizable to 2014 - 2019)

Quantitative Units

Revenue in USD Billion, Volumes in Units, Pricing in USD

Segments Covered

Treatment (Corticosteroids, Immunosuppressive Agents, Anticoagulants, Others), Route of Administration (Oral, Parenteral),End-Users (Hospitals, Homecare, Specialty Clinics, Others), Distribution Channel (Hospital Pharmacy, Online Pharmacy, Retail Pharmacy)

Countries Covered

U.S., Canada and Mexico in North America, Germany, France, U.K., Netherlands, Switzerland, Belgium, Russia, Italy, Spain, Turkey, Rest of Europe in Europe, China, Japan, India, South Korea, Singapore, Malaysia, Australia, Thailand, Indonesia, Philippines, Rest of Asia-Pacific (APAC) in the Asia-Pacific (APAC), Saudi Arabia, U.A.E, South Africa, Egypt, Israel, Rest of Middle East and Africa (MEA) as a part of Middle East and Africa (MEA), Brazil, Argentina and Rest of South America as part of South America

Market Players Covered

Novartis AG (Switzerland), Endo International Inc (Ireland), Teva Pharmaceutical Industries Ltd (Israel), Glenmark Pharmaceuticals Ltd (India), Cipla Inc (India), Dr Reddy's Laboratories Ltd (India), Abbott (U.S.), F. Hoffmann-La Roche Ltd (Switzerland.), Pfizer Inc (U.S.), Zydus Group (India), Lupin (India), Amorphex Therapeutics Holdings, Inc (U.S.), Bausch Health Companies Inc. (Canada.), Regeneron Pharmaceuticals Inc (U.S.), Astellas Pharma Inc. (Japan)

Market Opportunities

  • Increasing Demand of Diagnostic Tests
  • Increasing Demand for Retail Pharmacies

Market Definition

Temporal arteritis is also known as Horton's arteritis and is considered to be a severe form of vasculitis which means inflammation of the blood vessels. It is a potentially life-threatening inflammatory condition of the arteries. It can cause scalp tenderness and headaches. This condition usually occurs in temporal arteries and may occur in any medium to large artery of the body. As this condition generally occurs in aged population, it is also known as arteritis of the aged. Other names of temporal arteritis includes Horton disease, arteritis cranialis, and granulomatous arteritis.

Global Temporal arteritis Market Dynamics

Drivers

  • Increase in Autoimmune Disorders

According to National Institute of Environmental Health Sciences records, more than 80 autoimmune diseases have been identified, namely diabetes (type 1), lupus, multiple sclerosis, rheumatoid arthritis, and celiac disease. Rise in the occurrence of these diseases pushes the global temporal arteritis market. This factor boosts the growth of the market.

  • Rising Demand for Oral Drugs

Oral drugs is projected to boost the market growth. The segment is anticipated to accelerate the global market as most of the products are available in capsule and tablet form and it is a very convenient route of administration. Wide number of patients prefer this route and it leads to the faster recovery as well.

Opportunities

  • Increasing Demand of Diagnostic Tests

Several diagnostic tests are available for this treatment that are necessary for the quick recovery of the patients. Diagnosis of temporal arteritis is done by physical examination of the head, haemoglobin test to measure haemoglobin level in blood, or to detect oxygen-carrying protein in blood, liver function test to determine proper functioning of liver, haematocrit test to determine bloods with RBC cells. This boosts the growth of the market.

  • Increasing Demand for Retail Pharmacies

The rise in the number of temporal arteritis therapeutics being delivered through retail pharmacies and the surge in the number of retail pharmacies in developed countries create opportunities for the market growth. In addition to this, patients prefer retail pharmacies for purchasing drugs, as these are easily accessible.

 Restraints/Challenges

  • Side Effects of Treatment Procedures

There are several side effects that are associated with the treatment procedures of temporal arteries. It includes a greater chance of fractures as steroids can make the bones thinner and cause infections because steroids somewhat pull down the immune system. Thus, this hampers the growth of the market.

  • High Cost

The huge expenditure associated with temporal arteritis medications hamper the market growth. This disease involves treatment with corticosteroids, several immunosuppressive agents that demands huge expenditure. This acts as a major hindrance for the market.

This global temporal arteritis market report provides details of new recent developments, trade regulations, import-export analysis, production analysis, value chain optimization, market share, impact of domestic and localized market players, analyses opportunities in terms of emerging revenue pockets, changes in market regulations, strategic market growth analysis, market size, category market growths, application niches and dominance, product approvals, product launches, geographic expansions, technological innovations in the market. To gain more info on the global temporal arteritis market contact Data Bridge Market Research for an Analyst Brief, our team will help you take an informed market decision to achieve market growth.

Global Temporal Arteritis Market Scope

The global temporal arteritis market is segmented on the basis of treatment, route of administration, distribution channel and end-user. The growth amongst these segments will help you analyze meagre growth segments in the industries and provide the users with a valuable market overview and market insights to help them make strategic decisions for identifying core market applications.

Treatment

  • Corticosteroids
  • Aristocort
  • Bubbli-Pred
  • Immunosuppressive Agents
  • Adalimumab
  • Infliximab
  • Anticoagulants
  • Rivaroxaban
  • Dabigatran
  • Others

Route of Administration

  • Oral
  • Parenteral

End User

  • Hospitals
  • Homecare
  • Specialty Clinics
  • Others

Distribution Channel

  • Hospital Pharmacy
  • Online Pharmacy
  • Retail Pharmacy

Temporal Arteritis Market Regional Analysis/Insights

The global temporal arteritis market is analyzed and market size insights and trends are provided by treatment, route of administration, distribution channel and end-user as referenced above.

The major countries covered in the global temporal arteritis market report are the U.S., Canada and Mexico in North America, Germany, France, U.K., Netherlands, Switzerland, Belgium, Russia, Italy, Spain, Turkey, Rest of Europe in Europe, China, Japan, India, South Korea, Singapore, Malaysia, Australia, Thailand, Indonesia, Philippines, Rest of Asia-Pacific (APAC) in the Asia-Pacific (APAC), Saudi Arabia, U.A.E, South Africa, Egypt, Israel, Rest of Middle East and Africa (MEA) as a part of Middle East and Africa (MEA), Brazil, Argentina and Rest of South America as part of South America.

North America has been witnessing a positive growth for global temporal arteritis market throughout the forecasted period due to the increase prevalence of cardiovascular complications and advanced healthcare facilities.

Asia-Pacific dominates the market due to the increase’s cases of cardiovascular diseases and rapidly aging population.

The country section of the report also provides individual market impacting factors and changes in regulation in the market domestically that impacts the current and future trends of the market. Also, the presence and availability of global brands and their challenges faced due to large or scarce competition from local and domestic brands, impact of domestic tariffs and trade routes are considered while providing forecast analysis of the country data.   

Competitive Landscape and Global Temporal Arteritis Market Share Analysis

The global temporal arteritis market competitive landscape provides details by competitor. Details included are company overview, company financials, revenue generated, market potential, investment in research and development, new market initiatives, global presence, production sites and facilities, production capacities, company strengths and weaknesses, product launch, product width and breadth, application dominance. The above data points provided are only related to the companies' focus related to global temporal arteritis market

Key players operating in the global temporal arteritis market include:

  • Novartis AG (Switzerland)
  • Endo International Inc (Ireland)
  • Teva Pharmaceutical Industries Ltd (Israel)
  • Glenmark Pharmaceuticals Ltd (India)
  • Cipla Inc (India)
  • Dr Reddy's Laboratories Ltd (India)
  • Abbott (U.S.)
  • F. Hoffmann-La Roche Ltd (Switzerland)
  • Pfizer Inc (U.S.)
  • Zydus Group (India)
  • Lupin (India)
  • Amorphex Therapeutics Holdings, Inc (U.S.)
  • Bausch Health Companies Inc. (Canada)
  • Regeneron Pharmaceuticals Inc (U.S.)
  • Astellas Pharma Inc. (Japan)


SKU-

Please fill in the below form for detailed Table of Content

By clicking the "Submit" button, you are agreeing to the Data Bridge Market Research Privacy Policy and Terms and Conditions

Please fill in the below form for detailed List of Table

By clicking the "Submit" button, you are agreeing to the Data Bridge Market Research Privacy Policy and Terms and Conditions

Please fill in the below form for detailed List of Figure

By clicking the "Submit" button, you are agreeing to the Data Bridge Market Research Privacy Policy and Terms and Conditions

Please fill in the below form for Infographics

By clicking the "Submit" button, you are agreeing to the Data Bridge Market Research Privacy Policy and Terms and Conditions

Research Methodology:

Data collection and base year analysis are done using data collection modules with large sample sizes. The stage includes obtaining market information or related data through various sources and strategies. It includes examining and planning all the data acquired from the past in advance. It likewise envelops the examination of information inconsistencies seen across different information sources. The market data is analysed and estimated using market statistical and coherent models. Also, market share analysis and key trend analysis are the major success factors in the market report. To know more, please request an analyst call or drop down your inquiry.

The key research methodology used by DBMR research team is data triangulation which involves data mining, analysis of the impact of data variables on the market and primary (industry expert) validation. Data models include Vendor Positioning Grid, Market Time Line Analysis, Market Overview and Guide, Company Positioning Grid, Patent Analysis, Pricing Analysis, Company Market Share Analysis, Standards of Measurement, Global versus Regional and Vendor Share Analysis. To know more about the research methodology, drop in an inquiry to speak to our industry experts.

Please fill in the below form for Research Methodology

By clicking the "Submit" button, you are agreeing to the Data Bridge Market Research Privacy Policy and Terms and Conditions

Customization Available:

Data Bridge Market Research is a leader in advanced formative research. We take pride in servicing our existing and new customers with data and analysis that match and suits their goal. The report can be customized to include price trend analysis of target brands understanding the market for additional countries (ask for the list of countries), clinical trial results data, literature review, refurbished market and product base analysis. Market analysis of target competitors can be analyzed from technology-based analysis to market portfolio strategies. We can add as many competitors that you require data about in the format and data style you are looking for. Our team of analysts can also provide you data in crude raw excel files pivot tables (Fact book) or can assist you in creating presentations from the data sets available in the report.

Please fill in the below form for Available Customization

By clicking the "Submit" button, you are agreeing to the Data Bridge Market Research Privacy Policy and Terms and Conditions

Get online access to the report on the World's First Market Intelligence Cloud

  • Interactive Data Analysis Dashboard
  • Company Analysis Dashboard for high growth potential opportunities
  • Research Analyst Access for customization & queries
  • Competitor Analysis with Interactive dashboard
  • Latest News, Updates & Trend analysis
  • Harness the Power of Benchmark Analysis for Comprehensive Competitor Tracking
Request for Demo

FREQUENTLY ASK QUESTIONS

Factors such as increase in autoimmune disorders and rising demand for oral drugs are acting as the major drivers for the global temporal arteritis market.
Novartis AG (Switzerland), Endo International Inc (Ireland), Teva Pharmaceutical Industries Ltd (Israel), Glenmark Pharmaceuticals Ltd (India), Cipla Inc (India), Dr Reddy's Laboratories Ltd (India), Abbott (U.S.), F. Hoffmann-La Roche Ltd (Switzerland.), Pfizer Inc (U.S.), Zydus Group (India), Lupin (India), Amorphex Therapeutics Holdings, Inc (U.S.), Bausch Health Companies Inc. (Canada.), Regeneron Pharmaceuticals Inc (U.S.), Astellas Pharma Inc. (Japan).
Asia-Pacific dominates the market due to the increase’s cases of cardiovascular diseases and the rapidly aging population.
North America has been witnessing positive growth for the global temporal arteritis market throughout the forecasted period due to the increase prevalence of cardiovascular complications and advanced healthcare facilities.
Free Sample Report

CHOOSE LICENCE TYPE

  • 7000.00
  • 4800.00
  • 3000.00
  • 8000.00
  • 12000.00

Why Choose Us

Industry Coverage

DBMR works across the globe in multiple industries which equip us with knowledge across verticals and provide our clients with insights not only from their industry but how other industries will impact their ecosystem.

Regional Coverage

Coverage of Data Bridge is not restricted to developed or emerging economies. We work across the globe covering the largest array of countries where no other market research or business consulting firm has ever conducted research; creating growth opportunities for our clients in areas which are still unknown.

Technology Coverage

In today’s world, technology drives the market sentiment, so our vision is to provide our clients insights not only for developed technologies but upcoming and disrupting technological changes throughout the product lifecycle by enabling them with unforeseen opportunities in the market which will create disruption in their industry. This leads to innovation and our clients to come out as winners.

Goal Oriented Solutions

DBMR goal is to help our clients achieve their goals through our solutions; hence we formatively create the most appropriate solutions for our client needs, saving time and efforts for them to drive their grand strategies.

Unparallel Analyst Support

Our analysts take pride in our clients’ success. Unlike others, we believe in working along our clients to achieve their goals with 24 hours analyst support determining the correct needs and inspire innovation through service.

Banner

Client Testimonials